Stereospecific targeting of MTH1 by (S)-crizotinib as anticancer strategy

Activated Ras GTPase signalling is a critical driver of oncogenic transformation and malignant disease. Cellular models of RAS-dependent cancers have been used to identify experimental small-molecules, such as SCH51344, but their molecular mechanism of action remains generally enigmatic. Here, using...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Kilian V. M., Salah, Eidarus, Radic, Branka, Gridling, Manuela, Elkins, Jonathan M., Stukalov, Alexey, Jemth, Ann-Sofie, Gokturk, Camilla, Sanjiv, Kumar, Strömberg, Kia, Pham, Therese, Berglund, Ulrika Warpman, Colinge, Jacques, Bennett, Keiryn L., Loizou, Joanna, Helleday, Thomas, Knapp, Stefan, Superti-Furga, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150021/
https://www.ncbi.nlm.nih.gov/pubmed/24695225
http://dx.doi.org/10.1038/nature13194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150021/
https://www.ncbi.nlm.nih.gov/pubmed/24695225
http://dx.doi.org/10.1038/nature13194

Ejemplares similares